SCHEMBL7528577

SCHEMBL7528577

CC1CCC(C(C)C)C(OC(=O)c2ccccc2O)C1.CCCCC(CC)CC(=Cc1ccc(OC)cc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
LMNA P02545 3/20 0.40
MAPK1 P28482 5/20 0.39
MAPT P10636 4/20 0.39
ACLY P53396 1/20 0.38
NPSR1 Q6W5P4 5/20 0.38
HCRTR1 O43613 1/20 0.38
GLA P06280 1/20 0.38
IDE P14735 1/20 0.38
XBP1 P17861 1/20 0.38
P2RX4 Q99571 1/20 0.37
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
MITF O75030 2/20 0.35
HTT P42858 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533434 0.79 LMNA (0.52) ALDH1A1LMNAMAPK1MAPTNPC1
SCHEMBL126604 0.76 TDP1 (0.56) ALDH1A1MAPTTDP1
SCHEMBL17627791 0.76 TDP1 (0.56) ALDH1A1MAPTTDP1
SCHEMBL5198950 0.76 TDP1 (0.56) ALDH1A1MAPTTDP1
SCHEMBL14635938 0.75 ALDH1A1 (0.76) ALDH1A1HPGDLMNAMAPK1MAPT
SCHEMBL338235 0.75 ALDH1A1 (0.76) ALDH1A1HPGDLMNAMAPK1MAPT
SCHEMBL6851660 0.75 ALDH1A1 (0.76) ALDH1A1HPGDLMNAMAPK1MAPT
SCHEMBL17780 0.75 ALDH1A1 (0.76) ALDH1A1HPGDLMNAMAPK1MAPT
Octocrylene SCHEMBL9443700 0.74 ALDH1A1 (0.44) ALDH1A1HPGDLMNAMAPK1MAPT
Methacrylic Acid SCHEMBL21530855 0.72 ALDH1A1 (0.65) ALDH1A1HPGDLMNAMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020085981-A1 BENZOXAZOLE DERIVATIVES FOR USE IN COSMETIC COMPOSITIONS AND FOR STABILIZING SYNTHETIC POLYMERS GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC, A DELAWARE LIMITED LIABILITY COMPANY 2002-07-04 US disclosed
US-6399047-B1 HIGH ULTRAVIOLET RADIATION PROTECTION IN 320 TO 360 NM RANGE; PHOTOSTABILITY; SOLUBLE IN OILY SOLVENTS; TRIPHENYLAMINO-TRIAZINE SUBSTITUENT 3V SIGMA S.P.A. (IT) 2002-06-04 US disclosed
EP-1123934-A1 Benzoxazole derivatives useful as UV filters 3V SIGMA S.p.A (IT) 2001-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020085981-A1 BENZOXAZOLE DERIVATIVES FOR USE IN COSMETIC COMPOSITIONS AND FOR STABILIZING SYNTHETIC POLYMERS CUTA, TYR, PAOX ALDH1A1 605/4885HPGD 410/4885LMNA 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.